Corinne Chansiaud - UV Germi Financial Director

All Insiders . France . 
Stock . UV Germi SA . Stakeholders . Insider . Corinne Chansiaud
ALUVI Stock  EUR 2.55  0.06  2.41%   

Insider

Corinne Chansiaud is Financial Director of UV Germi SA
Phone33 5 55 88 18 88
Webhttps://www.uvgermi.fr

UV Germi Management Efficiency

The company has return on total asset (ROA) of 0.0204 % which means that it generated a profit of $0.0204 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0619) %, meaning that it generated substantial loss on money invested by shareholders. UV Germi's management efficiency ratios could be used to measure how well UV Germi manages its routine affairs as well as how well it operates its assets and liabilities.
UV Germi SA has accumulated 323.46 K in total debt with debt to equity ratio (D/E) of 14.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. UV Germi SA has a current ratio of 4.82, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist UV Germi until it has trouble settling it off, either with new capital or with free cash flow. So, UV Germi's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UV Germi SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ALUVI to invest in growth at high rates of return. When we think about UV Germi's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Pierre DecloedtBIO UV Group
N/A
Herve MBAEurobio Scientific SA
64
JeanMichel GrandmouginEurobio Scientific SA
62
Nicolas ReymondIntrasense
41
Thomas LamyBiosynex
N/A
Isabelle SostBIO UV Group
N/A
Thomas IffEurobio Scientific SA
N/A
David FranksNovacyt
N/A
Grald UlrichNovacyt
N/A
Jacques MartinEurobio Scientific SA
N/A
Bryan CloseNovacyt
N/A
Simon MarshallBIO UV Group
N/A
Lionel SeltzIntrasense
N/A
Denis FortierEurobio Scientific SA
55
Paul OladimejiNovacyt
N/A
LaurentEmmanuel MigeonBIO UV Group
N/A
Khalil FilaliIntrasense
N/A
Jeremy PeyronIntrasense
N/A
James McCarthyNovacyt
57
Benoit GillmannBIO UV Group
N/A
UV GERMI, Socit anonyme develops and manufactures UV sterilizers for water treatment applications. The company offers its products for applications in the areas of drinking water, waste water, water in public swimming pools, rain water, air, and surfaces, as well as industrial water in food processing, pharmaceutical, and cosmetic industries. UV GERMI operates under Pollution Treatment Controls classification in France and is traded on Paris Stock Exchange. It employs 30 people. UV Germi SA (ALUVI) is traded on Euronext Paris in France and employs 46 people.

Management Performance

Return On Equity-0.0619
Return On Asset0.0204

UV Germi SA Leadership Team

Elected by the shareholders, the UV Germi's board of directors comprises two types of representatives: UV Germi inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALUVI. The board's role is to monitor UV Germi's management team and ensure that shareholders' interests are well served. UV Germi's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UV Germi's outside directors are responsible for providing unbiased perspectives on the board's policies.
Willy Fortunato, Deputy COO
Sandrine Bordas, Deputy Director
Andres Bordas, Chairman CEO
Corinne Chansiaud, Financial Director

ALUVI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UV Germi a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0619
Return On Asset0.0204
Profit Margin(0.07) %
Operating Margin0.04 %
Current Valuation7.06 M
Shares Outstanding3.12 M
Shares Owned By Insiders46.65 %
Shares Owned By Institutions1.64 %
Price To Book1.13 X
Price To Sales1.37 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft

Additional Tools for ALUVI Stock Analysis

When running UV Germi's price analysis, check to measure UV Germi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UV Germi is operating at the current time. Most of UV Germi's value examination focuses on studying past and present price action to predict the probability of UV Germi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UV Germi's price. Additionally, you may evaluate how the addition of UV Germi to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY